Guide to the preparation, use and quality assurance of blood components

Size: px
Start display at page:

Download "Guide to the preparation, use and quality assurance of blood components"

Transcription

1 Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group Members of the TS066 working group Recommendation No. R (95) 15 of the Committee of Ministers...40 The Guide to the preparation, use and quality assurance of blood components, Appendix to Recommendation No. R (95) 15 PRINCIPLES Chapter 1. Principles of a quality system for blood establishments Introduction General Principles Elements of the quality system Premises Qualification and validation Process validation Control of equipment and materials Documentation Contract management Non-conformance Self-inspection, audits and improvements Quality monitoring and control

2 Chapter 2. Principles of donor selection Overview Donor screening Specific considerations for donors of different components Example of a donor screening questionnaire...95 Chapter 3. Principles of blood collection Overview Premises for donor sessions Equipment used at blood donation sessions Pre-donation checks and labelling Venepuncture Apheresis Repository of archive samples Management of adverse reactions in donors Donor clinic documentation Chapter 4. Principles of blood component processing storage and distribution Overview Processing procedures Choice of anti-coagulant and bag system Centrifugation of blood components Component separation Leucocyte depletion Freezing and thawing of plasma Open and closed systems and sterile connection devices Irradiation of blood components Prevention of CMV transmission Pathogen reduction Purity of components Bacterial safety of blood components

3 14. Storage of blood components Transportation of blood components Component information and principles of labelling Chapter 5. Principles of blood component monographs Definition and properties Preparation Requirements and quality control Storage and transport Labelling Warnings Chapter 6. Principles of blood components for foetal, neonatal and infant use Overview Components for intra-uterine transfusions Components for neonatal exchange transfusion Red cells for neonatal and infant small volume transfusion Fresh frozen plasma for neonatal and infant use Platelets for neonatal and infant use Chapter 7. Principles of pre-deposit autologous transfusion Overview Selection of patients for pre-deposit autologous transfusion and blood collection Preparation, storage and distribution of pre-deposit autologous components Chapter 8. Principles of immuno-haematology Overview Blood group serological investigations Validation and quality assurance Chapter 9. Principles of screening for markers of infection Overview (general comments for all mandatory tests) Algorithm for infectious marker screening and confirmatory testing

4 3. Confirmatory testing Nucleic acid screening Additional serological testing Chapter 10. Principles of haemovigilance Overview Prerequisites for implementation of a haemovigilance network Types of adverse reactions and adverse events collected in a haemovigilance network Tracing and recall of potentially infectious donations for HIV, HCV or HBV (look-back) Contracts between blood establishments and hospitals for haemovigilance Reporting of haemovigilance data Chapter 11. Principles of clinical use of blood Overview Elements for a quality system in clinical transfusion Clinical indications of blood components The request form Issuing blood components Administration of blood components Monitoring Transfusion complications Hospital transfusion committees STANDARDS Chapter 1. Standards for a quality system for blood establishments and hospital blood banks Introduction and general principles Elements of the quality system Chapter 2. Standards for selection of donors Overview Information to be provided to the donor

5 3. Medical assessment of the donor Donor deferral Specific standards for donors of different types of components Post-donation information Chapter 3. Standards for collection of blood and blood components Premises for donor sessions Procedures and equipment used at blood donation sessions Pre-donation checks Labelling Venepucture, bleeding and mixing Handling of filled containers and samples Special requirement for apheresis Repository of archive samples Chapter 4. Standards for blood component processing, storage and distribution Processing Component labelling and information Release of blood components Storage and distribution Irradiation of blood components Leucocyte depletion Bacterial safety Chapter 5. Component monographs Part A. Whole blood components Part B. Red cell components Part C. Platelet components Part D. Plasma components Part E. White cell components Chapter 6. Standards for blood components for intra-uterine, neonatal and infant use Part A. Components for intra-uterine transfusions

6 Part B. Components for neonatal exchange transfusion Part C. Components (small volume) for neonatal and infant transfusion Chapter 7. Standards for autologous pre-deposit transfusion Overview Selection of patients for PAT and blood collection Preparation, storage and distribution of pre-deposit autologous blood components Chapter 8. Standards for immuno-haematology Overview Selection and validation of reagents and methods Quality control Blood group testing of blood donations/donors Blood group testing of patients Chapter 9. Standards for screening for infectious markers Selection and validation of infectious marker tests Mandatory serological screening tests Additional serological screening tests Management of reactive results in serological screening tests Nucleic acid screening (NAT) Selective screening of donations Chapter 10. Standards for haemovigilance Overview Pre-requisites for implementation of a haemovigilance network Device defects Post-transfusion reported to the blood establishment Appendices List of definitions Abbreviations Recommendations and resolutions of the Council of Europe in the field of blood transfusion List of publications

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and

More information

Database on Blood Safety 2009 in ECO Member States

Database on Blood Safety 2009 in ECO Member States Database on Blood Safety 2009 in ECO Member States Section 1: Administrative Information Information provided by: 1.1 Name: 1.2 Title: 1.3 Position: 1.4 Organization: 1.5 Address: 1.6 Country: 1.7 Tel.

More information

Duration: 12 months May to April

Duration: 12 months May to April SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you

More information

The testing of Donated Blood and Components at NHSBT

The testing of Donated Blood and Components at NHSBT The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.

More information

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have

More information

Plasma for fractionation: South African Plasma Requirements

Plasma for fractionation: South African Plasma Requirements Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal

More information

Inspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03

Inspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03 1 of 7 6/10/2009 2:20 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040

More information

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies 2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1

More information

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection

More information

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company

More information

Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann

Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann Document Detail Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann Type: Document No.: Title: PMF IBTS SPEC IBTS/PMF/SPEC/0214[2] PLATELETS, ADULT DOSE WITH PLASMA / PAS, IRRADIATED

More information

QSEAL Recovered Plasma Specification

QSEAL Recovered Plasma Specification QSEAL Recovered Plasma Specification Background The is part of a series of standards that comprise the Plasma Protein Therapeutics Association (PPTA) QSEAL Standards Program. PPTA's Voluntary Standards

More information

ROLE AND IMPORTANCE OF QIsIN QM AND HV: FROM MONITORING TO IMPROVEMENT AND SAVING

ROLE AND IMPORTANCE OF QIsIN QM AND HV: FROM MONITORING TO IMPROVEMENT AND SAVING ROLE AND IMPORTANCE OF sin QM AND HV: FROM MONITORING TO IMPROVEMENT AND SAVING Tomislav Vuk Croatian Institute of Transfusion Medicine Zagreb, Croatia TRANSFUSION MEDICINE Special place of transfusion

More information

Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories

Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories Blood Products From the Donor to You Objectives Deliver a brief virtual tour of a blood center. Describe the number of donors needed to meet the

More information

Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann

Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann Document Detail Seirbhís Fuilaistriúcháin na héireann Type: Document No.: Title: PMF IBTS SPEC IBTS/PMF/SPEC/0219[1] PLATELETS, ADULT DOSE WITH PLASMA / PAS, WASHED, IRRADIATED Owner: 1895 REBECCA WALDEN

More information

Il ruolo delle VEQ per la sicurezza trasfusionale

Il ruolo delle VEQ per la sicurezza trasfusionale Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential

More information

Policy for the use of Cytomegalovirus (CMV) negative blood products

Policy for the use of Cytomegalovirus (CMV) negative blood products Policy for the use of Cytomegalovirus (CMV) negative blood products SharePoint Location Clinical Policies and Guidelines SharePoint Index Directory Cancer and Specialist Care Sub Area Haematology and Blood

More information

L 256/32 Official Journal of the European Union

L 256/32 Official Journal of the European Union L 256/32 Official Journal of the European Union 1.10.2005 COMMISSION DIRECTIVE 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards

More information

Adverse Reactions Associated with Methylene Blue Inactivated Fresh Frozen Plasma (MB FFP)

Adverse Reactions Associated with Methylene Blue Inactivated Fresh Frozen Plasma (MB FFP) Adverse Reactions Associated with Methylene Blue Inactivated Fresh Frozen Plasma (MB FFP) Constantina Politis Hellenic Coordinating Haemovigilance Centre (SKAE) Background Pathogen inactivation is expected

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately

More information

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood? What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to

More information

Blood Donor Counselling

Blood Donor Counselling Blood Donor Counselling A presentation for the Nepal Red Cross Society Blood Transfusion Service Dr Che Kit Lin On behalf of GAP and Hong Kong Red Cross 26 th August 2014 Purpose and Outcomes of Workshop

More information

Source of platelet concentrates FACHBEREICH MEDIZIN

Source of platelet concentrates FACHBEREICH MEDIZIN FACHBEREICH MEDIZIN Efficacy and safety of platelet concentrates from platelet apheresis donations or whole blood donations Gregor Bein Institute for Clinical Immunology and Transfusion Medicine Justus-Liebig-University

More information

HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012.

HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012. HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, 23-24 May, 212. BLOOD DONATION G I V I N G I S G O O D ORGAN COORDINATION OFFICE

More information

CTYOMEGALOVIRUS (CMV) - BACKGROUND

CTYOMEGALOVIRUS (CMV) - BACKGROUND CTYOMEGALOVIRUS (CMV) - BACKGROUND PURPOSE The flowing information provides guidance on the use of CMV negative blood components provided by the blood bank at the Royal Children s Hospital (RCH) including

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique

More information

AccuVert HBV Seroconversion Panel PHM941(M) ( )

AccuVert HBV Seroconversion Panel PHM941(M) ( ) PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics

More information

Impact of donor epidemiology and screening strategies on the safety of blood and plasma for fractionation

Impact of donor epidemiology and screening strategies on the safety of blood and plasma for fractionation IPFA 2 nd Asia Workshop in Yogyakarta Impact of donor epidemiology and screening strategies on the safety of blood and plasma for fractionation Yoshihiko Tani, MD, PhD Japanese Red Cross Osaka Blood Center

More information

National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands. TransMed conference Bhopal 18 November 2016

National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands. TransMed conference Bhopal 18 November 2016 Dr. Anton van Weert National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands TransMed conference Bhopal 18 Introduction Thank you! Anton van Weert, PhD, MBA Manager

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 21 September 2006 EMEA/CHMP/BWP/298390/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON

More information

CERTIFIED MAIL RETURN RECEIPT REQUESTED. Esther Hernandez President United States Blood Bank, Inc NW 95th Avenue Miami, Florida

CERTIFIED MAIL RETURN RECEIPT REQUESTED. Esther Hernandez President United States Blood Bank, Inc NW 95th Avenue Miami, Florida DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 CERTIFIED MAIL RETURN RECEIPT REQUESTED Esther Hernandez President United States Blood Bank, Inc. 2400 NW 95th

More information

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of

More information

Allogeneic donor selection and blood collection. by Mohammed Abu-basha

Allogeneic donor selection and blood collection. by Mohammed Abu-basha Allogeneic donor selection and blood collection 1 An allogeneic (also called homologous) donation (allo- from the Greek meaning "other") is when a donor gives blood for storage at a blood bank for transfusion

More information

Impact of multi-dye multiplex technology on testing algorithm

Impact of multi-dye multiplex technology on testing algorithm Impact of multi-dye multiplex technology on testing algorithm Lydia Blanco. Mª Isabel Gonzalez-Fraile Centro de Hemoterapia y Hemodonación de Castilla y León, España TTI EPIDEMIOLOGICAL DATA IN SPAIN NAT

More information

Lookback studies to assess viral risks The French experience

Lookback studies to assess viral risks The French experience Lookback studies to assess viral risks The French experience 2000-2012 S Laperche 1, MF Leconte des Floris 2, J Pillonel 3, L Hauser 2, C Lefort 2, JY Py 2, I Hervé 2, R Djoudi 2 For the French haemovigilance

More information

Chapter 17: Transfusion-Transmitted Infections (TTI)

Chapter 17: Transfusion-Transmitted Infections (TTI) Annual SHOT Report 2014 Supplementary Information Chapter 17: Transfusion-Transmitted s (TTI) The table below is an excerpt from the full Table 17.2 which can be viewed in the main report. Case reports

More information

CAUTION: Refer to the Document Library for the most recent version of this document. Cryoprecipitate Transfusion Guideline for Practice.

CAUTION: Refer to the Document Library for the most recent version of this document. Cryoprecipitate Transfusion Guideline for Practice. Directorate Department Year Version Number Central Index Number Endorsing Committee Date Endorsed Approval Committee Date Approved Author Name and Job Title Key Words (for search purposes) Date Published

More information

Blood is serious business

Blood is serious business Transfusion at RCH BLOOD TRANSFUSION Anthea Greenway Dept of Clinical Haematology >10000 fresh blood products per year Supports craniofacial and cardiac surgery Support bone marrow, liver transplant and

More information

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Ref. Ares(2015)2319265-03/06/2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Directorate D - Health systems and products D4 Substances of Human Origin and Tobacco Control Brussels,

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

CYTOMEGALOVIRUS (CMV) IgM ELISA Kit Protocol

CYTOMEGALOVIRUS (CMV) IgM ELISA Kit Protocol CYTOMEGALOVIRUS (CMV) IgM ELISA Kit Protocol (Cat. No.:EK-310-91) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED USE The

More information

15. Procuring, processing and transporting gametes and

15. Procuring, processing and transporting gametes and 15. Procuring, processing and transporting gametes and embryos Version 6.0 On this page: : Extracts from the HFE Act Directions HFEA guidance: Documented procedures: general Patient selection and procurement

More information

Policy for the use of Irradiated blood products

Policy for the use of Irradiated blood products Policy for the use of Irradiated blood products SharePoint Location General Policies and Guidelines SharePoint Index Directory Haematology and Blood Transfusion Sub Area - Key words (for search purposes)

More information

Human Cytomegalovirus IgM ELISA Kit

Human Cytomegalovirus IgM ELISA Kit Human Cytomegalovirus IgM Catalog No: IRAPKT2012 ELISA Kit Lot No: SAMPLE INTENDED USE The CMV IgM ELISA is intended for use in the detection of IgM antibodies to Cytomegalovirus (CMV) infection in human

More information

Haemovigilance in Europe: What do health authorities expect from haemovigilance?

Haemovigilance in Europe: What do health authorities expect from haemovigilance? Haemovigilance in Europe: What do health authorities expect from haemovigilance? Deirdre Fehily Substances of Human Origin Team Directorate General for and Food Safety Unit B4 Products: quality, safety

More information

EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY

EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2016)5909621-13/10/2016 EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY Directorate B - Health systems, medical products and innovation B4 Medical products: quality, safety

More information

Playing Detective: going in search of the source of infection. Su Brailsford Consultant in Epidemiology and Health Protection

Playing Detective: going in search of the source of infection. Su Brailsford Consultant in Epidemiology and Health Protection Playing Detective: going in search of the source of infection Su Brailsford Consultant in Epidemiology and Health Protection The Micro Services clinical team Are inquisitive Like problem solving Don t

More information

Structure and duties of Blood service

Structure and duties of Blood service NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,

More information

Transfusion Medicine in Saudi Arabia

Transfusion Medicine in Saudi Arabia Transfusion Medicine in audi Arabia, Mc, FRCPath, CTM Director of Blood Transfusion ervices Associate Professor in Haematology KAUH, Jeddah, audi Arabia Total Area1,960,582.00 sq Population27,019,731 (2006

More information

Annual SHOT Report 2016 Supplementary Information. Chapter 17: Transfusion-Transmitted Infections (TTI)

Annual SHOT Report 2016 Supplementary Information. Chapter 17: Transfusion-Transmitted Infections (TTI) Annual SHOT Report 2016 Supplementary Information Chapter 17: Transfusion-Transmitted s (TTI) The table below is an excerpt from the full Table 17.3 which can be viewed in the main report. Case reports

More information

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Transfusion 2004: Current Practice Standards Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Massive Transfusion Protocol (MTP) When should it be activated? Massive bleeding i.e. loss of one blood

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

Blood Supply and Wastage

Blood Supply and Wastage Blood Supply and Wastage Inga Willett Lab Matters, Oake Manor, 21 st June 2017 Blood supply UK supplied by 4 blood services: SNBTS NIBTS NHSBT WBS http://commons.wikimedia.org/wiki/file:uk_map_home_nations.png

More information

French National Experience. EFS Medical Director

French National Experience. EFS Medical Director HEMOVIGILANCE French National Experience Dr Rachid DJOUDI EFS Medical Director Tehran - December 2015 Hemovigilance in France In France, hemovigilance was defined by law since 1993 (last modified by article

More information

Human Cytomegalovirus Virus (CMV) IgG ELISA Kit

Human Cytomegalovirus Virus (CMV) IgG ELISA Kit Human Cytomegalovirus Virus Catalog No: IRAPKT1410 (CMV) IgG ELISA Kit Lot No: SAMPLE INTENDED USE The CMV IgG ELISA is intended for use in evaluating a patient s serologic status to cytomegalovirus (CMV)

More information

TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:

TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: A. TRANSFUSION RELATED FATALITY: FDA and MEDIC must be notified immediately, and subsequently in writing, when a possible transfusion related

More information

Accreditation in the Philippines

Accreditation in the Philippines 2015/LSIF/FOR/014 Accreditation in the Philippines Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October 2015 3/11/2015 ACCREDITATION in THE PHILIPPINES

More information

TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview

TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview IPFA Workshop Session 7: REGULATORY CONSIDERATIONS TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview Mary Lavithis, CSL Behring Australia Presented at: IPFA Asia

More information

SOP 17 BLOOD BANK. 3. Overall Responsibility: Blood Bank In-Change/Pathologist.

SOP 17 BLOOD BANK. 3. Overall Responsibility: Blood Bank In-Change/Pathologist. SOP 17 BLOOD BANK 1. Purpose: To ensure the availability of safe blood unit with facility for compatibility testing, storage and issue of blood in an aseptic environment on 24*7 basis trough trained professionals.

More information

Armed Services Blood Program

Armed Services Blood Program Armed Services Blood Program Defense Health Board Concerns Regarding the Collection and Transfusion of Non-FDA Compliant Blood Products in Theater Information Brief Defense Health Board 17 August 2009

More information

N.J.A.C. 8:8-1 et seq.

N.J.A.C. 8:8-1 et seq. N.J.A.C. 8:8-1 et seq. COLLECTION, PROCESSING, STORAGE AND DISTRIBUTION OF BLOOD BLOOD BANK INSPECTION CHECKLIST REGULATIONS N.J.A.C. 8:8-1.3 (a) N.J.A.C. 8:8-1.3 (b) N.J.A.C. 8:8-1.3 (c) N.J.A.C. 8:8-1.3

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Be ready. The INTERCEPT Blood System for Platelets and Plasma pathogen reduction system

Be ready. The INTERCEPT Blood System for Platelets and Plasma pathogen reduction system Be ready. The INTERCEPT Blood System for Platelets and Plasma pathogen reduction system INTERCEPT Blood System for Platelets an Blood safety is changing Safe donated blood is critical to improving certain

More information

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY Lexington, KY Page 1 of 13 Affected Sites: Enterprise Chandler X Good Samaritan I. PRINCIPLE: The UK Good Samaritan Hospital is dedicated to serve the patients with safe, high quality blood products and

More information

DIAGNOSTIC AUTOMATION, INC.

DIAGNOSTIC AUTOMATION, INC. DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

All institutions that transfuse blood components and products should implement national and local policies and written procedures for:

All institutions that transfuse blood components and products should implement national and local policies and written procedures for: 5.0 GENERAL GUIDE TO GOOD TRANSFUSION PRACTICE Blood and the various components prepared or manufactured from it are biologic (in the case of blood cells, living human tissues) products intended for use

More information

CAUTION: Refer to the Document Library for the most recent version of this policy. Policy for the use of Cytomegalovirus (CMV) negative blood products

CAUTION: Refer to the Document Library for the most recent version of this policy. Policy for the use of Cytomegalovirus (CMV) negative blood products Directorate Department Year Version Number Central Index Number Endorsing Committee Date Endorsed Approval Committee Date Approved Author Name and Job Title Key Words (for search purposes) Date Published

More information

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine BLOOD SAFETY STATUS IN INDONESIA Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine OUTLINE Background Blood services in Indonesia Regulation related to blood safety in Indonesia

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS Joana Bikulčienė Director of National blood center j.bikulciene@kraujodonoryste.lt Organizational structure of Lithuanian blood service 1 specialized

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia

2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia 2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply

More information

2014 report. The collection, testing and use of blood and blood components in Europe. M.P. Janssen 1 and G. Rautmann 2

2014 report. The collection, testing and use of blood and blood components in Europe. M.P. Janssen 1 and G. Rautmann 2 The collection, testing and use of blood and blood components in Europe 2014 report M.P. Janssen 1 and G. Rautmann 2 1. Julius Center for Health Sciences and Primary Care, University of Utrecht, Utrecht,

More information

Study of ChLIA and ELISA for TTI Markers in Blood Donors

Study of ChLIA and ELISA for TTI Markers in Blood Donors Study of ChLIA and ELISA for TTI Markers in Blood Donors Presenting Author - Miss Kiran Kachhadiya (Co-authors: Dr. Vachhani N., Mrs. Bhatt J, Dr. Jani F., Dr. Nandani S.) Life Blood Centre (Formerly known

More information

PROPOSED TECHNICAL REQUIREMENTS BLOOD AND BLOOD COMPONENTS. File 1 DRAFT FOR CONSULTATION PURPOSES ONLY

PROPOSED TECHNICAL REQUIREMENTS BLOOD AND BLOOD COMPONENTS. File 1 DRAFT FOR CONSULTATION PURPOSES ONLY PROPOSED TECHNICAL REQUIREMENTS BLOOD AND BLOOD COMPONENTS File 1 DRAFT FOR CONSULTATION PURPOSES ONLY ANNEX I INFORMATION REQUIREMENTS A. INFORMATION TO BE PROVIDED TO DONORS 1. Accurate but generally

More information

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE BMTCN REVIEW COURSE PRE-TRANSPLANT CARE Jennifer Shamai MS, RN, AOCNS, BMTCN Professional Practice Leader Department of Clinical Practice And Professional Education Click How to edit the Master Experts

More information

Keeping blood transfusions safe:

Keeping blood transfusions safe: ISP-WIV Seminar Diagnosis and surveillance of infectious diseases May 18 th, 2017 Keeping blood transfusions safe: the challenge of emerging infectious diseases Presented by Roland HÜBNER Superior Health

More information

Recombinant Treatments for Bleeding Disorders. An overview of treatments that are considered to have a low risk of viral transmission

Recombinant Treatments for Bleeding Disorders. An overview of treatments that are considered to have a low risk of viral transmission Recombinant Treatments for Bleeding Disorders An overview of treatments that are considered to have a low risk of viral transmission History of bleeding disorder treatments Recombinant products: A significant

More information

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

The Collection, Testing and Use of Blood and Blood Components in Europe

The Collection, Testing and Use of Blood and Blood Components in Europe The Collection, Testing and Use of Blood and Blood Components in Europe European Committee (Partial Agreement) on Blood Transfusion CD-P-TS 2011 report European Directorate Direction européenne for the

More information

Private Patients Pricelist

Private Patients Pricelist Private Patients Pricelist Valid 1 January 2017-31 December 2017 INF-ACC-006 1043973 Rev 0 (01/06/17) Reg No. 2000/026390/08 Private Diagnostic Services Nappi 10580 Packaging R75.14 R85.66 15016 Low Ionic

More information

Human tissues and cells annual report 2011

Human tissues and cells annual report 2011 Human tissues and cells annual report 2011 2012 Human tissues and cells Annual report Danish Health and Medicines Authority, 2012. This publication can be freely cited with a clear indication of source.

More information

Transfusion-transmitted HIV from seroconverted blood donors has not been identified in England since the introduction of HIV NAT screening

Transfusion-transmitted HIV from seroconverted blood donors has not been identified in England since the introduction of HIV NAT screening Transfusion-transmitted HIV from seroconverted blood donors has not been identified in England since the introduction of HIV NAT screening Bhavita Vishram Timeline of introduction of microbiological tests

More information

New Advances in Transfusion EM I LY CO BERLY, M D

New Advances in Transfusion EM I LY CO BERLY, M D New Advances in Transfusion EM I LY CO BERLY, M D TRANSFUSI ON M EDI CI NE FELLO W VANDERBI LT UNI VERSITY Objectives To discuss the terminology, components, transfusion risks, and dosing guidelines for

More information

to be notified: all parties involved in the graduated plan procedure. Annexes

to be notified: all parties involved in the graduated plan procedure. Annexes Paul-Ehrlich-Institut Postfach 63207 Langen, Germany To all marketing authorisation holders of cellular blood preparations and therapeutic single plasmas as well as authorisation holders of stem cells

More information

NAT Screening of Blood Donations in NBC, TRCS

NAT Screening of Blood Donations in NBC, TRCS IPFA/PEI, Italy NAT Screening of Blood Donations in NBC, TRCS 2000-2001 Clinical evaluation using COBAS AmpliiScreen HIV & HCV assays, (MP24) window period rate - 1 : 108,768 for HIV-1 and HCV 2002 Routine

More information

REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS. 19 November 1996 No I-1626 Vilnius

REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS. 19 November 1996 No I-1626 Vilnius REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS 19 November 1996 No I-1626 Vilnius (As last amended on 12 May 2016 No XII-2344) CHAPTER I GENERAL PROVISIONS

More information

Blood Product Modifications: Leukofiltration, Irradiation and Washing

Blood Product Modifications: Leukofiltration, Irradiation and Washing 1. Leukocyte Reduction Definitions and Standards: o Process also known as leukoreduction, or leukofiltration o Applicable AABB Standards, 25th ed. Leukocyte-reduced RBCs At least 85% of original RBCs

More information

Objectives. Methods. Results. Economic

Objectives. Methods. Results. Economic Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis [Adapted from Membe SK, Coyle D, Husereau D, Cimon

More information

Cryopreserved Human Hepatocytes (Cat # HP-F)

Cryopreserved Human Hepatocytes (Cat # HP-F) Certificate of Analysis Cryopreserved Human Hepatocytes (Cat # HP-F) This CoA represents a single Lot specific batch of cells. For details of current Lots available please contact us. Lot#: H0434 Gender

More information

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING 28-29October2010 Issue Summary Informational Topic: FDA s Geographic Donor Deferral Policy to Reduce the Possible Risk of Transmission

More information

NHSBT Board. Clinical Governance Report 01 October - 30 November 2016

NHSBT Board. Clinical Governance Report 01 October - 30 November 2016 17/06 NHSBT Board Clinical Governance Report 01 October - 30 November 2016 1. Status Public 2. Executive Summary The following should be noted: Two Serious Incidents were updated to the Clinical Audit

More information

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014 Probability of false initial and repeat ID-NAT reactive donations Marion Vermeulen IPFA Rome 2014 Overview of SANBS SANBS is a non profit organization Provides a vein to vein blood transfusion service

More information

A. Anti-HIV-1/2, HIV NAT Lookback: for those identified blood and blood components collected:

A. Anti-HIV-1/2, HIV NAT Lookback: for those identified blood and blood components collected: PURPOSE: MATERIALS: To outline a procedure for removing, recalling and/or correcting blood products that do not meet the requirements of the FDA, AABB, or the blood center. Recall/Market Withdrawal Form

More information

NATIONAL MARROW DONOR PROGRAM. Creating Connections. Saving Lives. Fran Rabe

NATIONAL MARROW DONOR PROGRAM. Creating Connections. Saving Lives. Fran Rabe Creating Connections. Saving Lives. National Marrow Donor Program (NMDP) Screening of International Donors Fran Rabe FDA Liaison Meeting January 4, 2007 U.S. Importation of Peripheral Blood Stem Cells

More information

Cataloguing-in-Publication (CIP) data. CIP data are available at

Cataloguing-in-Publication (CIP) data. CIP data are available at Blood Transfusion Services in South-East Asia Region. A 5-year review ISBN: 978-92-9022-651-2 World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike

More information

Update on WHO Prequalification of In Vitro Diagnostics

Update on WHO Prequalification of In Vitro Diagnostics Update on WHO Prequalification of In Vitro Diagnostics Robyn Meurant and Mercedes Perez Gonzalez Prequalification Team Diagnostics Assessment Essential Medicines and Health Products World Health Organization

More information

Abstract for Blood Bag Production. This abstract refers to blood bag production considering general and process information

Abstract for Blood Bag Production. This abstract refers to blood bag production considering general and process information Abstract for Blood Bag Production This abstract refers to blood bag production considering general and process information 1 BLOOD BAGS Blood donation and processing with these system is supplemented by

More information

Case 1. FDA, Legal, and EBAA Medical Standards Panel. Case 1. Case 1 6/25/2012. Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies

Case 1. FDA, Legal, and EBAA Medical Standards Panel. Case 1. Case 1 6/25/2012. Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies Case 1 FDA, Legal, and EBAA Medical Standards Panel Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies Medical Directors Symposium Eye Bank Association of America Annual Meeting 47 y/o

More information